NDC 0135-0096

Gaviscon Regular Strength

Aluminum Hydroxide And Magnesium Trisilicate

Gaviscon Regular Strength is a Oral Tablet, Chewable in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Aluminum Hydroxide; Magnesium Trisilicate.

• Product ID: 0135-0096_631c1308-db22-41c2-8031-8ad3511972b8
• NDC: 0135-0096
• Product Type: Human Otc Drug
• Proprietary Name: Gaviscon Regular Strength
• Generic Name: Aluminum Hydroxide And Magnesium Trisilicate
• Dosage Form: Tablet, Chewable
• Route of Administration: ORAL
• Marketing Start Date: 2011-06-13
• Marketing Category: NDA / NDA
• Application Number: NDA018685
• Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• Substance Name: ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
• Active Ingredient Strength: 80 mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0135-0096-26

100 TABLET, CHEWABLE in 1 BOTTLE (0135-0096-26)

• Marketing Start Date: 2011-06-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0135-0096-26 [00135009626]

Gaviscon Regular Strength TABLET, CHEWABLE

• Marketing Category: NDA
• Application Number: NDA018685
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-06-13
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
ALUMINUM HYDROXIDE	80 mg/1

OpenFDA Data

• SPL SET ID: 7f367927-c366-465c-a059-e2cfb337d562
• Manufacturer:
  • GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• UNII:
  • 0E53J927NA
  • 5QB0T2IUN0
  • C2E1CI501T
• RxNorm Concept Unique ID - RxCUI:
  • 308072
  • 731000
  • 1086458
  • 212978